These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 19086350)

  • 1. Hyperpigmentation with amisulpride.
    Mendhekar DN
    Aust N Z J Psychiatry; 2009 Jan; 43(1):88. PubMed ID: 19086350
    [No Abstract]   [Full Text] [Related]  

  • 2. Amenorrhea after sertraline introduction in an amisulpride-treated patient with undiagnosed polycystic ovary disease.
    Peritogiannis V; Goulia P; Pappas D; Hyphantis T; Mavreas V
    J Clin Psychopharmacol; 2007 Apr; 27(2):235-7. PubMed ID: 17414262
    [No Abstract]   [Full Text] [Related]  

  • 3. Photosensitivity reaction associated with selective serotonin re-uptake inhibitors: possible cross-sensitivity?
    Cheng YC; Huang MC
    Psychiatry Clin Neurosci; 2014 Mar; 68(3):244. PubMed ID: 24895743
    [No Abstract]   [Full Text] [Related]  

  • 4. Serotonin reuptake inhibitor provoked recurrence of alcohol hallucinosis--remission with additive amisulpride medication. A case report.
    Hermann D; Heinz A; Croissant B; Mann K
    Pharmacopsychiatry; 2004 Mar; 37(2):90-2. PubMed ID: 15048618
    [No Abstract]   [Full Text] [Related]  

  • 5. Amisulpride as add-on treatment for resistant obsessive-compulsive disorder: retrospective case series.
    Miodownik C; Bergman J; Lerner PP; Kreinin A; Lerner V
    Clin Neuropharmacol; 2015; 38(1):26-9. PubMed ID: 25580923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of olanzapine treatment for severe obsessive-compulsive disorder.
    Marazziti D; Pallanti S
    Am J Psychiatry; 1999 Nov; 156(11):1834-5. PubMed ID: 10553756
    [No Abstract]   [Full Text] [Related]  

  • 7. Sertraline in the treatment of clozapine-induced obsessive-compulsive behavior.
    Rahman MS; Grace JJ; Pato MT; Priest B
    Am J Psychiatry; 1998 Nov; 155(11):1629-30. PubMed ID: 9812137
    [No Abstract]   [Full Text] [Related]  

  • 8. Epileptiform seizure after sertraline treatment in an adolescent experiencing obsessive-compulsive disorder and presenting a rare pharmacogenetic status.
    Baumann P; Barbe R; Vabre-Bogdalova A; Garran E; Crettol S; Eap CB
    J Clin Psychopharmacol; 2006 Dec; 26(6):679-81. PubMed ID: 17110837
    [No Abstract]   [Full Text] [Related]  

  • 9. [Obsessive-compulsive disorder, frontostriatal system and the effect of the serotonergic system].
    Baving L; Schmidt MH
    Z Kinder Jugendpsychiatr Psychother; 2000 Feb; 28(1):35-44. PubMed ID: 10746297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serotonin reuptake inhibitor treatment of obsessive-compulsive symptoms in clozapine-medicated schizophrenia.
    Andrade C
    J Clin Psychiatry; 2012 Nov; 73(11):e1362-4. PubMed ID: 23218164
    [No Abstract]   [Full Text] [Related]  

  • 11. [The comparative study on the efficacy of the combination of serotonin reuptake inhibitor antidepressants and antipsychotics in the treatment of recurrent depressive disorders].
    D'iakonov AL; Lobanova IV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(11 Pt 2):61-6. PubMed ID: 23257758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amisulpiride augmentation in treatment resistant obsessive-compulsive disorder: an open trial.
    Metin O; Yazici K; Tot S; Yazici AE
    Hum Psychopharmacol; 2003 Aug; 18(6):463-7. PubMed ID: 12923825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quetiapine augmentation of sertraline in obsessive-compulsive disorder.
    Francobandiera G
    J Clin Psychiatry; 2002 Nov; 63(11):1046-7. PubMed ID: 12469688
    [No Abstract]   [Full Text] [Related]  

  • 14. Amisulpride-induced acute akathisia in OCD: an example of dysfunctional dopamine-serotonin interactions?
    Ersche KD; Cumming P; Craig KJ; Müller U; Fineberg NA; Bullmore ET; Robbins TW
    J Psychopharmacol; 2012 Jun; 26(6):887-90. PubMed ID: 21746752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Olanzapine-sertraline combination in schizophrenia with obsessive-compulsive disorder.
    Poyurovsky M; Kurs R; Weizman A
    J Clin Psychiatry; 2003 May; 64(5):611. PubMed ID: 12755669
    [No Abstract]   [Full Text] [Related]  

  • 16. Augmentation treatment with amisulpride in schizophrenic patients partially responsive to olanzapine.
    Molina JD; Toledo-Romero F; López-Rodríguez E; Amorin-Díaz M; Lerma-Carrillo I; López-Muñoz F
    Pharmacopsychiatry; 2011 Jun; 44(4):142-7. PubMed ID: 21710404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Weight gain during long-term treatment of obsessive-compulsive disorder: a prospective comparison between serotonin reuptake inhibitors.
    Maina G; Albert U; Salvi V; Bogetto F
    J Clin Psychiatry; 2004 Oct; 65(10):1365-71. PubMed ID: 15491240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative efficacy of SSRIs and amisulpride in burning mouth syndrome: a single-blind study.
    Maina G; Vitalucci A; Gandolfo S; Bogetto F
    J Clin Psychiatry; 2002 Jan; 63(1):38-43. PubMed ID: 11838624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cognitive improvement in schizophrenic patients does not require a serotonergic mechanism: randomized controlled trial of olanzapine vs amisulpride.
    Wagner M; Quednow BB; Westheide J; Schlaepfer TE; Maier W; Kühn KU
    Neuropsychopharmacology; 2005 Feb; 30(2):381-90. PubMed ID: 15578006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sertraline induced cervical dystonia in a patient of Obsessive Compulsive Disorder.
    Gupta B; Ahmad J; Kar SK; Shrivastava A
    Asian J Psychiatr; 2018 Jan; 31():77-78. PubMed ID: 29447992
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.